We are live on ! Find out more
AL

Aspiriant LLC Portfolio holdings

AUM $4.05B
1-Year Est. Return 19.01%
This Fund
S&P 500
This Quarter Est. Return
-3.17%
1 Year Est. Return
+19.01%
3 Year Est. Return
+47.13%
5 Year Est. Return
+48.95%
10 Year Est. Return
+147.53%
AUM
$1.82B
AUM Growth
-$52.1M
Cap. Flow
+$16.5M
Cap. Flow %
0.9%
Top 10 Hldgs %
59.54%
Holding
303
New
23
Increased
80
Reduced
125
Closed
29

Sector Composition

Rank Sector Weight
1 Technology 9.48%
2 Financials 2.69%
3 Communication Services 1.87%
4 Healthcare 1.22%
5 Consumer Staples 0.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VGK icon
301
Vanguard FTSE Europe ETF
VGK
$30.1B
-3,021
Closed -$206K
WDC icon
302
Western Digital
WDC
$159B
-4,392
Closed -$217K
XLY icon
303
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.7B
-2,034
Closed -$207K

Similar funds

Aspiriant LLC's Q1 2022 Portfolio in Review

As of Q1 2022, Aspiriant LLC held 303 positions worth $1.82B, down 2.8% from $1.87B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Aspiriant LLC's Q1 2022 filing shows 23 new, 80 increased, 125 reduced and 29 closed positions. Its largest new stake was RTX Corp: 12,007 shares worth $1.19M. The largest sale was Vanguard Morningstar Small-Cap Value ETF, an estimated $5.12M.

By sector, the portfolio is most concentrated in Technology at 9.5% of assets, down from 10% a quarter earlier, followed by Financials and Communication Services.

  • Aspiriant LLC's largest Q1 2022 buy was RTX Corp: 12,007 shares worth $1.19M.
  • Aspiriant LLC added most to Invesco S&P 500 Equal Weight ETF in Q1 2022, an estimated $8.7M increase.
  • Aspiriant LLC's biggest Q1 2022 reduction was Vanguard Morningstar Small-Cap Value ETF, cutting an estimated $5.12M.
  • Aspiriant LLC fully exited Markel Group in Q1 2022, selling an estimated $2.05M.
  • Aspiriant LLC's ten largest holdings make up 60% of its $1.82B portfolio in Q1 2022.
  • Aspiriant LLC opened 23 new positions and closed 29 in Q1 2022.
  • Aspiriant LLC's portfolio value fell 2.8% quarter-over-quarter to $1.82B.

Based on Aspiriant LLC's 13F filing for Q1 2022, filed 6 May 2022.